YINasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends December 31

111, Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026

$3.13+0.00 (+0.16%)

Close on Oct 19, 2026

111, Inc. income statement

AnnualQuarterlyTTM

Millions of CNY, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31
Revenue	12,556	14,401	14,948	13,517	12,426	8,203	3,952	1,786	959	874
Cost of Revenue	11,833	13,572	14,099	12,677	11,805	7,837	3,787	74	56	–
Gross Profit	723	829	849	840	621	366	165	104	80	74
Selling, General & Admin	328	385	673	664	720	528	464	359	244	314
Selling & Marketing	259	314	448	458	513	400	341	260	190	253
General & Administrative	69	71	224	206	207	128	124	99	53	61
Advertising Expenses	32	52	36	36	30	38	30	30	63	126
Total Costs & Expenses	12,558	14,399	15,298	13,888	13,068	8,676	4,446	2,186	1,214	1,238
Operating Income	-2.38	2.11	-350	-371	-642	-473	-494	-400	-254	-364
Interest Expense	36	28	20	13	5.49	8.82	3.62	–	0.06	0.75
Interest & Investment Income	3.89	7.04	8.83	8.12	9.78	6.31	4.80	4.35	4.01	2.31
Other Non-Operating Income	11	-0.60	7.61	8.13	15	3.16	0.83	12	4.23	-3.35
Asset Impairment Charges	0	0	0	0	0	0	11	0	0	0
Gain (Loss) on Sale of Assets	-0.04	-0.03	-0.99	-1.37	0.05	-0.16	0.01	-1.11	0.01	-0.02
Pretax Income	-23	-21	-353	-376	-621	-467	-502	-382	-249	-363
Income Tax Expense	0.01	0.10	0.25	0	0	0	0	0.01	–	–
Net Income incl. Noncontrolling Interests	-23	-21	-353	-376	-621	-467	-502	-382	-249	-363
Minority Interest in Earnings	-4.09	-8.40	-17	-15	-28	0	-2.22	-1.95	-0.75	-0.77
Net Income	–	–	–	–	–	–	–	-382	-249	-363
Net Income to Common	-66	-65	-393	-417	-670	-457	-500	-380	-249	-418
EPS (Basic)(per share)	-0.38	-0.38	-2.33	-2.50	-4.04	-2.77	-3.05	-3.82	-3.45	-5.81
EPS (Diluted)(per share)	-0.38	-0.38	-2.33	-2.50	-4.04	-2.77	-3.05	-3.82	-3.45	-5.81
Shares Outstanding (Basic, Weighted)(shares)	174	172	169	167	166	165	164	99	72	72
Shares Outstanding (Diluted, Weighted)(shares)	174	172	169	167	166	165	164	99	72	72
EBITDA	9.46	19	-328	-330	-615	-459	-482	-389	-239	-352
Provision for Credit Losses	0	0	0	0	0	0	0	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 5.8%
Operating margin: -0.0%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 1.09
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 26.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.